Attached files

file filename
EX-99.1 - Intellect Neurosciences, Inc.v173890_ex99-1.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 10, 2010
 
Intellect Neurosciences, Inc.
(Exact Name Of Registrant As Specified In Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)
 
333-128226
20-2777006
(Commission File Number)
(I.R.S. Employer Identification No.)
   
7 West 18th Street, New York, NY
10011
(Address of Principal Executive Offices)
(Zip Code)
 
(212) 448-9300
(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


Item 8.01. Other Events.

On February 10, 2010, Intellect Neurosciences, Inc. (OTCBB: ILNS) issued a press release announcing that it reached a preliminary agreement with certain of its significant shareholders to provide interim funding and assist the Company in efforts to secure additional financing.  A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is furnished as part of this Report on Form 8-K:
 
Exhibit
 
Description
 
99.1
 
Press release dated February 10, 2010.
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
       
 
INTELLECT NEUROSCIENCES, INC.
 
       
Date: February 10, 2010
By:  
/s/ Elliot Maza
 
 
Name: Elliot Maza
 
 
Title: President and CFO